Cryo-Cell International, Inc. (CCEL) Revenue History
Annual and quarterly revenue from 2013 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
CCEL Revenue Growth
Revenue Breakdown (FY 2024)
CCEL's revenue distribution by segment and geography for fiscal year 2024
By Product/Segment
By Geography
CCEL Revenue Analysis (2013–2024)
As of May 6, 2026, Cryo-Cell International, Inc. (CCEL) generated trailing twelve-month (TTM) revenue of $31.7 million, reflecting slight decline in growth of -3.0% year-over-year. The most recent quarter (Q3 2025) recorded $7.8 million in revenue, down 1.3% sequentially.
Looking at the longer-term picture, CCEL's 5-year compound annual growth rate (CAGR) stands at +0.1%, indicating moderate growth over time. The company achieved its highest annual revenue of $32.0 million in 2024, representing a new all-time high.
Revenue diversification analysis shows CCEL's business is primarily driven by Processing And Storage Fees (99%), Public Banking (1%), and Product (0%). With over half of revenue concentrated in Processing And Storage Fees, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including VCEL (+16.5% YoY), BLFS (+47.4% YoY), and IART (+1.2% YoY), CCEL has underperformed the peer group in terms of revenue growth. Compare CCEL vs VCEL →
CCEL Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| CCELCurrent | $32M | -3.0% | +0.1% | 10.9% | |
 VCEL | $276M | +16.5% | +17.3% | 4.0% | |
 BLFS | $96M | +47.4% | +14.9% | -12.6% | |
 IART | $1.6B | +1.2% | +3.6% | 4.2% | |
 OSUR | $115,021 | -99.9% | -76.8% | -59.2% | |
 NTRA | $1.7B | +38.2% | +41.2% | -13.1% |
CCEL Historical Revenue Data (2013–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $32.0M | +2.0% | $24.0M | 75.2% | $3.5M | 10.9% |
| 2023 | $31.3M | +3.3% | $22.9M | 73.1% | $-12,304,032 | -39.3% |
| 2022 | $30.3M | +5.0% | $21.5M | 71.0% | $4.0M | 13.3% |
| 2021 | $28.9M | -7.3% | $19.9M | 68.9% | $4.0M | 13.9% |
| 2020 | $31.1M | -2.1% | $21.5M | 69.0% | $7.7M | 24.6% |
| 2019 | $31.8M | +8.9% | $21.8M | 68.5% | $5.1M | 15.9% |
| 2018 | $29.2M | +15.1% | $20.7M | 70.8% | $5.2M | 17.8% |
| 2017 | $25.4M | +9.8% | $18.7M | 73.5% | $5.0M | 19.7% |
| 2016 | $23.1M | +9.7% | $17.4M | 75.0% | $434K | 1.9% |
| 2015 | $21.1M | +4.8% | $15.5M | 73.3% | $2.9M | 13.9% |
See CCEL's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CCEL Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CCEL vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCCEL — Frequently Asked Questions
Quick answers to the most common questions about buying CCEL stock.
Is CCEL's revenue growth accelerating or slowing?
CCEL revenue growth slowed to -3.0%, below the 5-year CAGR of +0.1%. TTM revenue is $32M. The deceleration marks a shift from historical growth rates.
What is CCEL's long-term revenue growth rate?
Cryo-Cell International, Inc.'s 5-year revenue CAGR of +0.1% reflects the variable expansion pattern. Current YoY growth of -3.0% is near this long-term average.
How is CCEL's revenue distributed by segment?
CCEL reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2013-2024 are available for download. Segment mix reveals concentration and diversification trends.